We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
36.06%
This Fund
S&P 500
This Quarter
Est. Return
+4.66%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.94B
AUM Growth
+$1.21B
(+21%)
Cap. Flow
+$1.03B
Cap. Flow
% of AUM
14.89%
Top 10 Holdings %
Top 10 Hldgs %
53.97%
Holding
274
New
81
Increased
95
Reduced
45
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$73.4M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$72M |
| 3 |
Johnson & Johnson
JNJ
|
+$64.2M |
| 4 |
Colgate-Palmolive
CL
|
+$62.8M |
| 5 |
Dentsply Sirona
XRAY
|
+$52.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pacira BioSciences
PCRX
|
+$73.1M |
| 2 |
Freshpet
FRPT
|
+$58.3M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$48M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$43.7M |
| 5 |
KYNB
Kyntra Bio
KYNB
|
+$32.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.57% |
| 2 | Consumer Staples | 5.26% |
| 3 | Consumer Discretionary | 4.88% |
| 4 | Technology | 4.62% |
| 5 | Communication Services | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Rekor Systems
REKR
$89M
| $7.52M | 0.11% |
+6,015,147
| New | +$9.57M |
|
102
Albertsons Companies
ACI
$5.86B
| $6.73M | 0.1% |
+324,000
| New | +$6.69M |
|
103
Capri Holdings
CPRI
$1.72B
| $6.16M | 0.09% |
131,000
+44,000
| +51% | +$2.36M |
|
|
ESPR
104
DELISTED
Esperion Therapeutics
ESPR
| $5.85M | 0.08% |
+3,679,279
| New | +$19M |
|
|
VSXY
105
Victoria's Secret
VSXY
$7.43B
| $5.62M | 0.08% |
+164,615
| New | +$6.1M |
|
|
FREE
106
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $5.5M | 0.08% |
2,150,000
-325,802
| -13% | -$1.11M |
|
107
Nomad Foods
NOMD
$1.65B
| $5.34M | 0.08% |
285,000
+185,000
| +185% | +$3.27M |
|
108
Generac Holdings
GNRC
$12.5B
| $5.18M | 0.07% |
+48,000
| New | +$5.55M |
|
109
BioNTech
BNTX
$22.9B
| $4.48M | 0.06% |
36,000
-4,000
| -10% | -$549K |
|
110
Energous
WATT
$98.5M
| $4.24M | 0.06% |
+13,100
| New | +$5.58M |
|
111
RH
RH
$3.56B
| $4.19M | 0.06% |
+17,215
| New | +$5M |
|
|
CMRX
112
DELISTED
Chimerix, Inc.
CMRX
| $4.13M | 0.06% |
3,276,000
+76,000
| +2% | +$124K |
|
|
AJRD
113
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $3.82M | 0.06% |
+68,000
| New | +$3.8M |
|
|
OTLY
114
Oatly Group
OTLY
$437M
| $3.63M | 0.05% |
75,000
+7,500
| +11% | +$350K |
|
115
Momentus
MNTS
$82.7M
| $3.47M | 0.05% |
+475
| New | +$4.81M |
|
116
RenovoRx
RNXT
$51.9M
| $3.43M | 0.05% |
+982,921
| New | +$3.46M |
|
117
Advantage Solutions
ADV
$337M
| $3.34M | 0.05% |
84,440
| – | – |
|
|
VAPO
118
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $2.99M | 0.04% |
+568,842
| New | +$5.28M |
|
|
NOVN
119
DELISTED
Novan, Inc. Common Stock
NOVN
| $2.92M | 0.04% |
+2,247,248
| New | +$3.12M |
|
120
Dollar Tree
DLTR
$24.9B
| $2.87M | 0.04% |
+20,000
| New | +$2.9M |
|
|
DRRX
121
DELISTED
DURECT Corp
DRRX
| $2.76M | 0.04% |
+610,000
| New | +$3.31M |
|
122
ASP Isotopes
ASPI
$516M
| $2.7M | 0.04% |
+3,164,557
| New | +$4.96M |
|
|
UPH
123
DELISTED
UpHealth, Inc.
UPH
| $2.46M | 0.04% |
+1,650,000
| New | +$3.64M |
|
124
Chewy
CHWY
$9.59B
| $2.24M | 0.03% |
+60,000
| New | +$2.48M |
|
|
SRGA
125
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $2.09M | 0.03% |
1,309,000
+528,000
| +68% | +$1.07M |
|
Similar funds
CRC
RMDI
F
EW
O
DSC
ACM
PI
Armistice Capital's Q1 2023 Portfolio in Review
As of Q1 2023, Armistice Capital held 274 positions worth $6.94B, up 21% from $5.73B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Armistice Capital deployed $1.03B of net new capital in Q1 2023, opening 81 new positions and adding to 95 existing holdings. Its largest new stake was DICE Therapeutics, Inc. Common Stock: 1,376,000 shares worth $39.4M.
By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 46% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
On the sell side, the largest reduction was Freshpet, an estimated $58.3M trimmed.
- Armistice Capital's largest Q1 2023 buy was DICE Therapeutics, Inc. Common Stock: 1,376,000 shares worth $39.4M.
- Armistice Capital added most to UnitedHealth in Q1 2023, an estimated $73.4M increase.
- Armistice Capital's biggest Q1 2023 reduction was Freshpet, cutting an estimated $58.3M.
- Armistice Capital fully exited Pacira BioSciences in Q1 2023, selling an estimated $73.1M.
- Armistice Capital's ten largest holdings make up 54% of its $6.94B portfolio in Q1 2023.
- Armistice Capital opened 81 new positions and closed 48 in Q1 2023.
- Armistice Capital's portfolio value rose 21% quarter-over-quarter to $6.94B.
Based on Armistice Capital's 13F filing for Q1 2023, filed 15 May 2023.